Last Friday Tandem stock came under a short attack with short sellers posting news of a death of a patient who was using a Tandem pump. Now before we go any further a few words about the FDA adverse event reporting system, which is vastly outdated, subject to wide interpretation, abused constantly yet the only system we have. Medical device companies are given an incredible amount of latitude as what they report and how they report. Some report every little incident no matter how inconsequential, others seek to avoid reporting until absolutely necessary.
Now we should say that anyone who . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.